Frequency, reasons, and risk factors of entacapone discontinuation in Parkinson disease
To determine the rate of and identify reasons for discontinuation of entacapone treatment in Parkinson disease patients. A retrospective study design was used, including medical record reviews and telephone call to the patient as needed. Two hundred and twenty-two Parkinson disease patients were sta...
Gespeichert in:
Veröffentlicht in: | Clinical neuropharmacology 2004-05, Vol.27 (3), p.119-123 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!